You are here

  • Home
  • Archive
  • Volume 14, Issue 4
  • Swissped-RECOVERY: masked independent adjudication for the interpretation of non-randomised treatment in a two-arm open-label randomised controlled trial (methylprednisolone vs immunoglobulins) in Paediatric Inflammatory Multisystem Syndrome Temporally A…

Article info

Article menu
Paediatrics
Original research
Swissped-RECOVERY: masked independent adjudication for the interpretation of non-randomised treatment in a two-arm open-label randomised controlled trial (methylprednisolone vs immunoglobulins) in Paediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2 (PIMS-TS) involving 10 secondary and tertiary paediatric hospitals in Switzerland

Authors

  • Nina Schöbi Paediatrics, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland PubMed articlesGoogle scholar articles
  • Carlos Sanchez Paediatric Research Centre, University Children's Hospital Basel, University of Basel, Basel, Switzerland PubMed articlesGoogle scholar articles
  • Tatjana Welzel Paediatric Research Centre, University Children's Hospital Basel, University of Basel, Basel, Switzerland Pediatric Rheumatology, University Children's Hospital Basel, University of Basel, Basel, Switzerland PubMed articlesGoogle scholar articles
  • Alasdair Bamford Paediatric Infectious Diseases, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK Infection, Immunity and Inflammation, UCL Great Ormond Street Institute of Child Health, London, UK PubMed articlesGoogle scholar articles
  • Kate Webb Division of Paediatric Rheumatology, School of Child and Adolescent Health, Red Cross War Memorial Children's Hospital, University of Cape Town, Cape Town, South Africa PubMed articlesGoogle scholar articles
  • Pablo Rojo Pediatrics, Hospital Universitario Doce de Octubre. Universidad Complutense. Instituto de Investigación 12 Octubre, Madrid, Spain PubMed articlesGoogle scholar articles
  • Adriana Tremoulet Paediatrics, University of California San Diego, Rady Children's Hospital San Diego, San Diego, California, USA PubMed articlesGoogle scholar articles
  • Andrew Atkinson Paediatric Research Centre, University Children's Hospital Basel, University of Basel, Basel, Switzerland Infectious Diseases, Washington University in St. Louis School of Medicine, St. Louis, St Louis, Missouri, USA PubMed articlesGoogle scholar articles
  • Luregn J Schlapbach Department of Intensive Care and Neonatalogy, and Children's Research Center, University Children's Hospital Zürich, Zurich, Switzerland Child Health Research Centre, The University of Queensland, and Paediatric Intensive Care Unit, Queensland Children's Hospital, Saint Lucia, Queensland, Australia PubMed articlesGoogle scholar articles
  • Julia Anna Bielicki Paediatric Research Centre, University Children's Hospital Basel, University of Basel, Basel, Switzerland Centre for Neonatal and Paediatric Infection, St George’s University, London, UK PubMed articlesGoogle scholar articles
  • The Swissped-RECOVERY trial group
    Google scholar articles
  1. Correspondence to Dr Julia Anna Bielicki; JuliaAnna.Bielicki{at}ukbb.ch
View Full Text

Citation

Schöbi N, Sanchez C, Welzel T, et al
Swissped-RECOVERY: masked independent adjudication for the interpretation of non-randomised treatment in a two-arm open-label randomised controlled trial (methylprednisolone vs immunoglobulins) in Paediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2 (PIMS-TS) involving 10 secondary and tertiary paediatric hospitals in Switzerland
BMJ Open 2024;14:e078137. doi: 10.1136/bmjopen-2023-078137

Publication history

  • Received July 25, 2023
  • Accepted March 25, 2024
  • First published April 25, 2024.
Online issue publication 
April 25, 2024
Previous versions
Review history

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.